M. Raptopoulou‐Gigi

Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study

Yun‐Fan Liaw, M. Raptopoulou‐Gigi, Hugo Cheinquer et al. · Hepatology · 2011 · 228 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study

George Papatheodoridis, Spilios Manolakopoulos, Giota Touloumi et al. · Gut · 2011 · 186 citations

Medicine, Pharmacology, Pharmacotherapy +17

Interferon-alpha 2b treatment of chronic hepatitis C in haemodialysis patients.

M. Raptopoulou‐Gigi, Sofia Spaia, A. Garifallos et al. · PubMed · 1995 · 64 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1–TH2 cytokine profile in subjects with self‐limited disease

Eleni Gigi, M. Raptopoulou‐Gigi, A. Kalogeridis et al. · Journal of Viral Hepatitis · 2007 · 51 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Hepatocellular carcinoma risk in <scp>HB</scp>eAg‐negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort

George Papatheodoridis, Spilios Manolakopoulos, Giota Touloumi et al. · Journal of Viral Hepatitis · 2014 · 46 citations · Full text

Medicine, Oncology, Pharmacotherapy +17